She has led BCT through its development, pilot evaluation, and successful launch as a nationwide, non-profit service in 2008. BCT currently lists over 600 studies and attracts over 120,000 visits per year. As an extension of BCT, Dr. Cohen and her team recently launched Metastatic Trial Search, a matching tool designed for patients with metastatic breast cancer, in collaboration with five breast cancer advocacy organizations including the Young Survival Coalition. Dr. Cohen is frequently invited to talk about clinical trials to patient groups and is actively involved in the Metastatic Breast Cancer Alliance. She has a BA in Biology from Brooklyn College and a Ph.D. in Pathology from Cornell University. Dr. Cohen is a breast cancer survivor.